Thus, an evaluation of GRPR expression level in breast cancer might provide essential predictive information for the selection of, e.g., GRPR-targeted radionuclide therapy or, possibly, therapy based on blocking ER signaling. The gene discussed is GRPR; the disease is breast cancer.